Anna M. Lee and Rachel F. Tyndale

Drugs and genotypes: how pharmacogenetic information could improve smoking cessation treatment
J Psychopharmacol 2006 20: 7-14. [Abstract] [PDF] [References]  

Gavin P. Reynolds, Matthew J. Hill, and Shona L. Kirk

The 5-HT2C receptor and antipsychoticinduced weight gain – mechanisms and genetics
J Psychopharmacol 2006 20: 15-18. [Abstract] [PDF] [References]  

Mary-Anne Enoch, Pei-Hong Shen, Ke Xu, Colin Hodgkinson, and David Goldman

Using ancestry-informative markers to define populations and detect population stratification
J Psychopharmacol 2006 20: 19-26. [Abstract] [PDF] [References]  

Julia Kirchheiner, Dirk Gründemann, and Edgar Schömig

Contribution of allelic variations in transporters to the phenotype of drug response
J Psychopharmacol 2006 20: 27-32. [Abstract] [PDF] [References]  

Francis E. Lotrich, Robert R. Bies, Gwenn S. Smith, and Bruce G. Pollock

Relevance of assessing drug concentration exposure in pharmacogenetic and imaging studies
J Psychopharmacol 2006 20: 33-40. [Abstract] [PDF] [References]  

Wesley K. Kroeze and Bryan L. Roth

Screening the receptorome
J Psychopharmacol 2006 20: 41-46. [Abstract] [PDF] [References]  

J. Craig Nelson, Laura Portera, and Andrew C. Leon

Assessment of outcome in depression
J Psychopharmacol 2006 20: 47-53. [Abstract] [PDF] [References]  

C. Lindsay Devane, Zachary N. Stowe, Jennifer L. Donovan, D. Jeffrey Newport, Page B. Pennell, James C. Ritchie, Michael J. Owens, and Jun-Sheng Wang

Therapeutic drug monitoring of psychoactive drugs during pregnancy in the genomic era: challenges and opportunities
J Psychopharmacol 2006 20: 54-59. [Abstract] [PDF] [References]  

Murray Esler, Marlies Alvarenga, Ciaran Pier, Jeff Richards, Assam El-Osta, David Barton, Deepak Haikerwal, David Kaye, Markus Schlaich, Ling Guo, Garry Jennings, Flora Socratous, and Gavin Lambert

The neuronal noradrenaline transporter, anxiety and cardiovascular disease
J Psychopharmacol 2006 20: 60-66. [Abstract] [PDF] [References]  

John Geddes

Meta-analysis in the assessment of treatment outcome
J Psychopharmacol 2006 20: 67-71. [Abstract] [PDF] [References]  

Greer M. Murphy, Jr

Application of microarray technology in psychotropic drug trials
J Psychopharmacol 2006 20: 72-78. [Abstract] [PDF] [References]  

Carmine M. Pariante

The glucocorticoid receptor: part of the solution or part of the problem?
J Psychopharmacol 2006 20: 79-84. [Abstract] [PDF] [References]  

Sheldon H. Preskorn

Pharmacogenomics, informatics, and individual drug therapy in psychiatry: past, present and future
J Psychopharmacol 2006 20: 85-94. [Abstract] [PDF] [References]  

Svein G. Dahl and Ingebrigt Sylte

From genomics to drug targets
J Psychopharmacol 2006 20: 95-99. [Abstract] [PDF] [References]  

Andrea L. Malizia

The role of emission tomography in pharmacokinetic and pharmacodynamic studies in clinical psychopharmacology
J Psychopharmacol 2006 20: 100-107. [Abstract] [PDF] [References]  

Abstracts
J Psychopharmacol 2006 20: 108-111. [PDF]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.